Definitive Contract 75N93023C00018
Award Date
7/5/23
Potential Completion Date
1/25/26
Potential Value
$19M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Seattle, WA 98102, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
19
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $575,850.00 fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the In Vitro Antimicrobial Assessments 2011-2018 indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract was awarded to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute located in Seattle, Washington. The contract is for unspecified "OTHER FUNCTIONS" and does not have a set-aside designation. As a prime...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Access To Advanced Health Institute (AAHI), doing business as Aahi, Idri, and Infectious Disease Research Institute. The $2,980 contract is for infectious disease research and development, specifically related to vaccine adjuvants. AAHI is a non-profit biotech research institute that combines academic...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute. The $638,080 contract is for in vitro assessment of antimicrobial activity, under the In Vitro Antimicrobial Assessments 2011-2018 master IDIQ contract. The period of performance is from November 4, 2016 to October 31, 2017. AAHI is a prime contractor experienced in...
This is a $18,844,434.24 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute, for the advanced development and clinical evaluation of a synthetic intranasal Entamoeba histolytica vaccine containing an adjuvant. The contract does not have a set-aside designation. The contract involves several subcontractors, including the University of Wisconsin System,...
This is a federal contract award to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute located in Seattle, Washington. The contract, titled "PANACEA", is a non-set-aside Other Transaction Agreement with a ceiling value of $2,854,631.10 and an ultimate completion date of August 29, 2024. AAHI, doing business as Aahi, Idri, and Infectious Disease Research Institute, is a prime contractor experienced in conducting research and development of vaccine...
This is a cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Vaxine PTY LTD, a for-profit organization located in Australia. The $18,541,473.00 contract is for the "ADVANCED DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES". The contract has an end date of August 14, 2023 and was initially awarded on September 20, 2018. This contract...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute in Seattle, Washington. The contract is for in vitro characterization of anti-mycobacterial activity, as part of the larger In Vitro Antimicrobial Assessments 2011-2018 contract vehicle. The contract has a ceiling value of...
This is a $26,065,720.00 cost-plus-fixed-fee delivery order awarded to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is for the manufacture of human flu challenge material, which supports IAVI's mission to develop safe and effective preventive vaccines for infectious diseases. The award is part of IAVI's existing indefinite...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $780,764 firm fixed price purchase order contract to Access To Advanced Health Institute, doing business as Aahi, Idri, Infectious Disease Research Institute, located in Rockville, Maryland. Under the contract, Idri will provide investigational products GLA-SE adjuvant formulation and lyophilized ID93 from Idri for clinical trials funded by NIAID's Division of AIDS. As the prime contractor, Idri...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $432,452.00 cost-plus-fixed-fee delivery order contract to the International AIDS Vaccine Initiative (IAVI), a non-profit organization, for a feasibility assessment of HIV envelope protein antigens. The contract does not have a set-aside designation. IAVI has conducted research, development, and advocacy to advance vaccines and antibodies for infectious...